Business context and reporting period
Filing identity: The supplied filing is Schweitzer-Mauduit International, Inc. (SWM), Form 10-Q for the quarter and six months ended June 30, 2014—not Mativ Holdings, Inc. Verify the entity and period before relying on this summary.
SWM produced specialty papers, reconstituted tobacco and filtration materials. Filtration results include DelStar, acquired in December 2013. Results are unaudited; interim performance is not necessarily indicative of full-year results.
Financial performance
| Metric | Q2 2014 | Q2 2013 | Six months 2014 | Six months 2013 |
|---|---|---|---|---|
| Net sales | $203.6M | $196.5M | $408.3M | $391.0M |
| Gross profit / margin | $59.2M / 29.1% | $64.9M / 33.0% | $116.8M / 28.6% | $127.6M / 32.6% |
| Operating profit / margin | $30.5M / 15.0% | $42.1M / 21.4% | $63.6M / 15.6% | $83.8M / 21.4% |
| Net income | $25.0M | $26.6M | $48.2M | $56.7M |
| Diluted EPS | $0.81 | $0.84 | $1.56 | $1.80 |
| Cash provided by operations | $39.1M | $40.5M | $57.4M | $81.8M |
Six-month capital spending was $15.1M. Cash at June 30 was $291.4M, of which $287.1M was held by foreign subsidiaries. Total debt was $449.1M ($444.9M long-term); debt to capital was 45.2%, versus 40.7% at year-end 2013. Credit-facility availability was $68.6M, with a further $45.0M available under overdraft facilities and lines of credit. SWM was in compliance with its debt covenants.
Material changes versus prior comparable periods
- Sales increased 3.6% in Q2 and 4.4% year to date, principally because of DelStar and favorable foreign exchange. Excluding Filtration, legacy-segment sales were pressured by lower volumes, unfavorable mix and lower prices.
- Paper sales fell 9.2% in Q2 and 8.2% year to date; Reconstituted Tobacco sales fell 21.0% and 20.7%, respectively. Filtration contributed $32.1M of Q2 sales and $63.8M year to date.
- Gross profit declined despite higher consolidated sales. Management cited legacy-segment volume and pricing pressure, unfavorable mix, lower-volume manufacturing inefficiencies and higher energy and labor costs. DelStar contributed $8.7M of Q2 gross profit and $13.8M year to date; first-half Filtration results also included a $3.3M acquired-inventory fair-value adjustment.
- Operating profit fell 27.6% in Q2 and 24.1% year to date. Higher debt following the DelStar acquisition contributed to increased interest expense. Lower effective tax rates partly moderated the decline in net income.
- First-half operating cash flow decreased $24.4M, reflecting lower earnings and a larger working-capital cash outflow ($24.1M versus $11.2M). The company repurchased $52.6M of shares and paid $22.0M in dividends; the $50M repurchase authorization was fully used.
Outlook, commentary and risks
- No full-year earnings or revenue guidance is provided. Management expected reconstituted tobacco volumes and operating profit to decline meaningfully in 2014 versus 2013, and anticipated continued cigarette-paper demand pressure absent new LIP regulations.
- Management viewed South Korea’s targeted July 2015 LIP implementation as a potential demand opportunity, but noted timing and financial impact were uncertain. CTS began operations in Q2, expects first customer sales in late 2014 and full capacity by 2016; further 2014 start-up expenses were expected.
- Management expected DelStar-related filtration growth, particularly in water filtration, and potential commercial synergies. It also expected cost savings from the Spay, France early-retirement program, with $3.5M–$4.0M of 2014 expenditures and savings anticipated from the second half of 2014.
- Key exposures include tobacco-industry attrition, competition and pricing, lower customer demand, commodity and labor cost inflation, foreign exchange, acquisition integration and execution, and risks associated with international joint ventures.
- Brazil tax disputes involved approximately $42M of raw-material ICMS assessments, of which about $19M was covered by an indemnification, plus approximately $21M of electricity-related assessments. SWM recorded no liability, believed the matters would be resolved favorably, and gave no assurance of outcome. Environmental and other proceedings were also disclosed.
Most important facts to verify
- Confirm the filing is the intended company and period: it identifies SWM, not Mativ Holdings, Inc.
- Assess whether sustained legacy-segment volume, mix and pricing pressure could offset DelStar’s contribution and projected filtration growth.
- Review leverage, debt-facility headroom, covenant compliance and the concentration of cash in foreign subsidiaries.
- Track operating cash conversion and working-capital movements, alongside continued capital spending, dividends and any future repurchases.
- Follow the Brazil tax proceedings and confirm the status of the indemnification and any potential amnesty resolution.
- Monitor CTS start-up costs, customer qualification and sales timing, and the timing and realized savings of the French restructuring program.